aluates Reports

$ 0.0

Automative

Global Gout Therapeutics Market Insights, Forecast to 2029

Published Date: August 2023

Report Code: QYRE-Auto-13N13479

Global Gout Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Gout Therapeutics Market Insights, Forecast to 2029

Code: QYRE-Auto-13N13479

Report

August 2023

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Takeda Pharmaceutical Company

Regeneron Pharmaceuticals

Gout Therapeutics Market Size

The global Gout Therapeutics market is projected to grow from US$ 4939.6 million in 2023 to US$ 10260 million by 2029, at a Compound Annual Growth Rate (CAGR) of 13.0% during the forecast period.

Gout Therapeutics Market

Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries.

Market Analysis and Insights: Global Gout Therapeutics Market

Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to patients on the basis of severity of the condition. Introduction of urate-lowering agents is one of the primary driver of the gout therapeutics market. First line therapies such as Febuxostat and Allopurinol are now replaced urate-lowering agents such as Lesinurad, which help in reducing pain as well as negotiate the risk of joint destruction. The growing popularity of OTC drugs such as Oral colchicine, corticosteroids, and NASAIDs, which are quite effective in moderate gout indications, are also favoring the global gout therapeutics market in the positive direction. Technological advancements in medical imaging is another factor augmenting the demand in the gout therapeutics market. On the other hand, low levels of physician and patient awareness, heavy dependency on generic drugs, and use of CAM for the treatment of gout are restraining factors over the global gout therapeutics market.

Report Includes

This report presents an overview of global market for Gout Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Gout Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gout Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gout Therapeutics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Gout Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Gout Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Takeda Pharmaceutical Company, Novartis, AstraZeneca, GlaxoSmithKline, Merck and Regeneron Pharmaceuticals, etc.

Scope of Gout Therapeutics Market Report

Report Metric	Details
Report Name	Gout Therapeutics Market
Accounted market size in 2023	US$ 4939.6 million
Forecasted market size in 2029	US$ 10260 million
CAGR	13.0
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	NSAIDs Corticosteroids Colchicine Urate-Lowering Agents
Segment by Application	Acute Gout Chronic Gout
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda Pharmaceutical Company, Novartis, AstraZeneca, GlaxoSmithKline, Merck, Regeneron Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Gout Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gout Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gout Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Gout Therapeutics Market growing?

Ans: The Gout Therapeutics Market witnessing a CAGR of 13.0 during the forecast period 2023-2029.

What is the Gout Therapeutics Market size in 2029?

Ans: The global Gout Therapeutics market is projected to grow from US$ 4939.6 million in 2023 to US$ 10260 million by 2029, at a Compound Annual Growth Rate (CAGR) of 13.0% during the forecast period.

Who are the main players in the Gout Therapeutics Market report?

Ans: The main players in the Gout Therapeutics Market are Takeda Pharmaceutical Company, Novartis, AstraZeneca, GlaxoSmithKline, Merck, Regeneron Pharmaceuticals

What are the Application segmentation covered in the Gout Therapeutics Market report?

Ans: The Applications covered in the Gout Therapeutics Market report are Acute Gout, Chronic Gout

What are the Type segmentation covered in the Gout Therapeutics Market report?

Ans: The Types covered in the Gout Therapeutics Market report are NSAIDs, Corticosteroids, Colchicine, Urate-Lowering Agents

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gout Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 NSAIDs

1.2.3 Corticosteroids

1.2.4 Colchicine

1.2.5 Urate-Lowering Agents

1.3 Market by Application

1.3.1 Global Gout Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Acute Gout

1.3.3 Chronic Gout

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gout Therapeutics Market Perspective (2018-2029)

2.2 Global Gout Therapeutics Growth Trends by Region

2.2.1 Gout Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Gout Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Gout Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Gout Therapeutics Market Dynamics

2.3.1 Gout Therapeutics Industry Trends

2.3.2 Gout Therapeutics Market Drivers

2.3.3 Gout Therapeutics Market Challenges

2.3.4 Gout Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Gout Therapeutics by Players

3.1.1 Global Gout Therapeutics Revenue by Players (2018-2023)

3.1.2 Global Gout Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Gout Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Gout Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Gout Therapeutics Market Concentration Ratio

3.4.1 Global Gout Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gout Therapeutics Revenue in 2022

3.5 Global Key Players of Gout Therapeutics Head office and Area Served

3.6 Global Key Players of Gout Therapeutics, Product and Application

3.7 Global Key Players of Gout Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gout Therapeutics Breakdown Data by Type

4.1 Global Gout Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Gout Therapeutics Forecasted Market Size by Type (2024-2029)

5 Gout Therapeutics Breakdown Data by Application

5.1 Global Gout Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Gout Therapeutics Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Gout Therapeutics Market Size (2018-2029)

6.2 North America Gout Therapeutics Market Size by Type

6.2.1 North America Gout Therapeutics Market Size by Type (2018-2023)

6.2.2 North America Gout Therapeutics Market Size by Type (2024-2029)

6.2.3 North America Gout Therapeutics Market Share by Type (2018-2029)

6.3 North America Gout Therapeutics Market Size by Application

6.3.1 North America Gout Therapeutics Market Size by Application (2018-2023)

6.3.2 North America Gout Therapeutics Market Size by Application (2024-2029)

6.3.3 North America Gout Therapeutics Market Share by Application (2018-2029)

6.4 North America Gout Therapeutics Market Size by Country

6.4.1 North America Gout Therapeutics Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Gout Therapeutics Market Size by Country (2018-2023)

6.4.3 North America Gout Therapeutics Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Gout Therapeutics Market Size (2018-2029)

7.2 Europe Gout Therapeutics Market Size by Type

7.2.1 Europe Gout Therapeutics Market Size by Type (2018-2023)

7.2.2 Europe Gout Therapeutics Market Size by Type (2024-2029)

7.2.3 Europe Gout Therapeutics Market Share by Type (2018-2029)

7.3 Europe Gout Therapeutics Market Size by Application

7.3.1 Europe Gout Therapeutics Market Size by Application (2018-2023)

7.3.2 Europe Gout Therapeutics Market Size by Application (2024-2029)

7.3.3 Europe Gout Therapeutics Market Share by Application (2018-2029)

7.4 Europe Gout Therapeutics Market Size by Country

7.4.1 Europe Gout Therapeutics Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Gout Therapeutics Market Size by Country (2018-2023)

7.4.3 Europe Gout Therapeutics Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Gout Therapeutics Market Size (2018-2029)

8.2 China Gout Therapeutics Market Size by Type

8.2.1 China Gout Therapeutics Market Size by Type (2018-2023)

8.2.2 China Gout Therapeutics Market Size by Type (2024-2029)

8.2.3 China Gout Therapeutics Market Share by Type (2018-2029)

8.3 China Gout Therapeutics Market Size by Application

8.3.1 China Gout Therapeutics Market Size by Application (2018-2023)

8.3.2 China Gout Therapeutics Market Size by Application (2024-2029)

8.3.3 China Gout Therapeutics Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Gout Therapeutics Market Size (2018-2029)

9.2 Asia Gout Therapeutics Market Size by Type

9.2.1 Asia Gout Therapeutics Market Size by Type (2018-2023)

9.2.2 Asia Gout Therapeutics Market Size by Type (2024-2029)

9.2.3 Asia Gout Therapeutics Market Share by Type (2018-2029)

9.3 Asia Gout Therapeutics Market Size by Application

9.3.1 Asia Gout Therapeutics Market Size by Application (2018-2023)

9.3.2 Asia Gout Therapeutics Market Size by Application (2024-2029)

9.3.3 Asia Gout Therapeutics Market Share by Application (2018-2029)

9.4 Asia Gout Therapeutics Market Size by Region

9.4.1 Asia Gout Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Gout Therapeutics Market Size by Region (2018-2023)

9.4.3 Asia Gout Therapeutics Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Gout Therapeutics Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Gout Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Gout Therapeutics Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Gout Therapeutics Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Gout Therapeutics Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Gout Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Gout Therapeutics Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Gout Therapeutics Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Gout Therapeutics Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Gout Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Gout Therapeutics Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Gout Therapeutics Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Gout Therapeutics Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Takeda Pharmaceutical Company

11.1.1 Takeda Pharmaceutical Company Company Details

11.1.2 Takeda Pharmaceutical Company Business Overview

11.1.3 Takeda Pharmaceutical Company Gout Therapeutics Introduction

11.1.4 Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2018-2023)

11.1.5 Takeda Pharmaceutical Company Recent Developments

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Gout Therapeutics Introduction

11.2.4 Novartis Revenue in Gout Therapeutics Business (2018-2023)

11.2.5 Novartis Recent Developments

11.3 AstraZeneca

11.3.1 AstraZeneca Company Details

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca Gout Therapeutics Introduction

11.3.4 AstraZeneca Revenue in Gout Therapeutics Business (2018-2023)

11.3.5 AstraZeneca Recent Developments

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Details

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline Gout Therapeutics Introduction

11.4.4 GlaxoSmithKline Revenue in Gout Therapeutics Business (2018-2023)

11.4.5 GlaxoSmithKline Recent Developments

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck Gout Therapeutics Introduction

11.5.4 Merck Revenue in Gout Therapeutics Business (2018-2023)

11.5.5 Merck Recent Developments

11.6 Regeneron Pharmaceuticals

11.6.1 Regeneron Pharmaceuticals Company Details

11.6.2 Regeneron Pharmaceuticals Business Overview

11.6.3 Regeneron Pharmaceuticals Gout Therapeutics Introduction

11.6.4 Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2018-2023)

11.6.5 Regeneron Pharmaceuticals Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Takeda Pharmaceutical Company

Regeneron Pharmaceuticals

List of Tables

Table 1. Global Gout Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of NSAIDs

Table 3. Key Players of Corticosteroids

Table 4. Key Players of Colchicine

Table 5. Key Players of Urate-Lowering Agents

Table 6. Global Gout Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 7. Global Gout Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 8. Global Gout Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 9. Global Gout Therapeutics Market Share by Region (2018-2023)

Table 10. Global Gout Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 11. Global Gout Therapeutics Market Share by Region (2024-2029)

Table 12. Gout Therapeutics Market Trends

Table 13. Gout Therapeutics Market Drivers

Table 14. Gout Therapeutics Market Challenges

Table 15. Gout Therapeutics Market Restraints

Table 16. Global Gout Therapeutics Revenue by Players (2018-2023) & (US$ Million)

Table 17. Global Gout Therapeutics Revenue Share by Players (2018-2023)

Table 18. Global Top Gout Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gout Therapeutics as of 2022)

Table 19. Global Gout Therapeutics Industry Ranking 2021 VS 2022 VS 2023

Table 20. Global 5 Largest Players Market Share by Gout Therapeutics Revenue (CR5 and HHI) & (2018-2023)

Table 21. Global Key Players of Gout Therapeutics, Headquarters and Area Served

Table 22. Global Key Players of Gout Therapeutics, Product and Application

Table 23. Global Key Players of Gout Therapeutics, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Gout Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 26. Global Gout Therapeutics Revenue Market Share by Type (2018-2023)

Table 27. Global Gout Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 28. Global Gout Therapeutics Revenue Market Share by Type (2024-2029)

Table 29. Global Gout Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 30. Global Gout Therapeutics Revenue Share by Application (2018-2023)

Table 31. Global Gout Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 32. Global Gout Therapeutics Revenue Share by Application (2024-2029)

Table 33. North America Gout Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 34. North America Gout Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 35. North America Gout Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 36. North America Gout Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 37. North America Gout Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. North America Gout Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 39. North America Gout Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 40. Europe Gout Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 41. Europe Gout Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 42. Europe Gout Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 43. Europe Gout Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 44. Europe Gout Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 45. Europe Gout Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 46. Europe Gout Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 47. China Gout Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 48. China Gout Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 49. China Gout Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 50. China Gout Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 51. Asia Gout Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 52. Asia Gout Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 53. Asia Gout Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 54. Asia Gout Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 55. Asia Gout Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 56. Asia Gout Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 57. Asia Gout Therapeutics Market Size by Region (2024-2029) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Gout Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Gout Therapeutics Market Size by Type (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Gout Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Gout Therapeutics Market Size by Application (2024-2029) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Gout Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 63. Middle East, Africa, and Latin America Gout Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Gout Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 65. Takeda Pharmaceutical Company Company Details

Table 66. Takeda Pharmaceutical Company Business Overview

Table 67. Takeda Pharmaceutical Company Gout Therapeutics Product

Table 68. Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2018-2023) & (US$ Million)

Table 69. Takeda Pharmaceutical Company Recent Developments

Table 70. Novartis Company Details

Table 71. Novartis Business Overview

Table 72. Novartis Gout Therapeutics Product

Table 73. Novartis Revenue in Gout Therapeutics Business (2018-2023) & (US$ Million)

Table 74. Novartis Recent Developments

Table 75. AstraZeneca Company Details

Table 76. AstraZeneca Business Overview

Table 77. AstraZeneca Gout Therapeutics Product

Table 78. AstraZeneca Revenue in Gout Therapeutics Business (2018-2023) & (US$ Million)

Table 79. AstraZeneca Recent Developments

Table 80. GlaxoSmithKline Company Details

Table 81. GlaxoSmithKline Business Overview

Table 82. GlaxoSmithKline Gout Therapeutics Product

Table 83. GlaxoSmithKline Revenue in Gout Therapeutics Business (2018-2023) & (US$ Million)

Table 84. GlaxoSmithKline Recent Developments

Table 85. Merck Company Details

Table 86. Merck Business Overview

Table 87. Merck Gout Therapeutics Product

Table 88. Merck Revenue in Gout Therapeutics Business (2018-2023) & (US$ Million)

Table 89. Merck Recent Developments

Table 90. Regeneron Pharmaceuticals Company Details

Table 91. Regeneron Pharmaceuticals Business Overview

Table 92. Regeneron Pharmaceuticals Gout Therapeutics Product

Table 93. Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2018-2023) & (US$ Million)

Table 94. Regeneron Pharmaceuticals Recent Developments

Table 95. Research Programs/Design for This Report

Table 96. Key Data Information from Secondary Sources

Table 97. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Gout Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Gout Therapeutics Market Share by Type: 2022 VS 2029

Figure 3. NSAIDs Features

Figure 4. Corticosteroids Features

Figure 5. Colchicine Features

Figure 6. Urate-Lowering Agents Features

Figure 7. Global Gout Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 8. Global Gout Therapeutics Market Share by Application: 2022 VS 2029

Figure 9. Acute Gout Case Studies

Figure 10. Chronic Gout Case Studies

Figure 11. Gout Therapeutics Report Years Considered

Figure 12. Global Gout Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 13. Global Gout Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 14. Global Gout Therapeutics Market Share by Region: 2022 VS 2029

Figure 15. Global Gout Therapeutics Market Share by Players in 2022

Figure 16. Global Top Gout Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gout Therapeutics as of 2022)

Figure 17. The Top 10 and 5 Players Market Share by Gout Therapeutics Revenue in 2022

Figure 18. North America Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 19. North America Gout Therapeutics Market Share by Type (2018-2029)

Figure 20. North America Gout Therapeutics Market Share by Application (2018-2029)

Figure 21. North America Gout Therapeutics Market Share by Country (2018-2029)

Figure 22. United States Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Canada Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Europe Gout Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 25. Europe Gout Therapeutics Market Share by Type (2018-2029)

Figure 26. Europe Gout Therapeutics Market Share by Application (2018-2029)

Figure 27. Europe Gout Therapeutics Market Share by Country (2018-2029)

Figure 28. Germany Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. France Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. U.K. Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Italy Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Russia Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Nordic Countries Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. China Gout Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 35. China Gout Therapeutics Market Share by Type (2018-2029)

Figure 36. China Gout Therapeutics Market Share by Application (2018-2029)

Figure 37. Asia Gout Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 38. Asia Gout Therapeutics Market Share by Type (2018-2029)

Figure 39. Asia Gout Therapeutics Market Share by Application (2018-2029)

Figure 40. Asia Gout Therapeutics Market Share by Region (2018-2029)

Figure 41. Japan Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. South Korea Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. China Taiwan Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Southeast Asia Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. India Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Australia Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Gout Therapeutics Market Size YoY (2018-2029) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Gout Therapeutics Market Share by Type (2018-2029)

Figure 49. Middle East, Africa, and Latin America Gout Therapeutics Market Share by Application (2018-2029)

Figure 50. Middle East, Africa, and Latin America Gout Therapeutics Market Share by Country (2018-2029)

Figure 51. Brazil Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 52. Mexico Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Turkey Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Saudi Arabia Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. Israel Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. GCC Countries Gout Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. Takeda Pharmaceutical Company Revenue Growth Rate in Gout Therapeutics Business (2018-2023)

Figure 58. Novartis Revenue Growth Rate in Gout Therapeutics Business (2018-2023)

Figure 59. AstraZeneca Revenue Growth Rate in Gout Therapeutics Business (2018-2023)

Figure 60. GlaxoSmithKline Revenue Growth Rate in Gout Therapeutics Business (2018-2023)

Figure 61. Merck Revenue Growth Rate in Gout Therapeutics Business (2018-2023)

Figure 62. Regeneron Pharmaceuticals Revenue Growth Rate in Gout Therapeutics Business (2018-2023)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Osteoarthritis Pain Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6Z3154

Fri Mar 15 00:00:00 UTC 2024

Add to Cart

Global Osteoarthritis Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31R1606

Fri Mar 15 00:00:00 UTC 2024

Add to Cart

Global Osteoarthritis Medications Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-28E5704

Tue Mar 12 00:00:00 UTC 2024

Add to Cart

Global Juvenile Idiopathic Arthritis Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-21W1178

Tue Mar 05 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions